REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 87 filers reported holding REATA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $371,000 | -31.4% | 6,613 | 0.0% | 0.04% | -27.1% |
| Q3 2018 | $541,000 | +67.5% | 6,613 | -28.5% | 0.06% | +59.5% |
| Q2 2018 | $323,000 | +70.0% | 9,244 | 0.0% | 0.04% | +60.9% |
| Q1 2018 | $190,000 | -27.5% | 9,244 | 0.0% | 0.02% | -28.1% |
| Q4 2017 | $262,000 | -8.7% | 9,244 | 0.0% | 0.03% | -17.9% |
| Q3 2017 | $287,000 | -1.7% | 9,244 | 0.0% | 0.04% | -9.3% |
| Q2 2017 | $292,000 | +39.7% | 9,244 | 0.0% | 0.04% | +30.3% |
| Q1 2017 | $209,000 | +3.5% | 9,244 | 0.0% | 0.03% | -2.9% |
| Q4 2016 | $202,000 | +61.6% | 9,244 | +94.8% | 0.03% | +54.5% |
| Q3 2016 | $125,000 | +33.0% | 4,746 | 0.0% | 0.02% | +22.2% |
| Q2 2016 | $94,000 | – | 4,746 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 3,063,567 | $298,453,000 | 49.63% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 150,000 | $14,613,000 | 19.62% |
| Corriente Advisors, LLC | 300,000 | $29,226,000 | 14.82% |
| Prosight Management, LP | 114,554 | $11,160,000 | 5.31% |
| MADDEN SECURITIES Corp | 43,927 | $4,279,000 | 3.18% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $2,958,000 | 2.24% |
| Biondo Investment Advisors, LLC | 99,652 | $9,708,000 | 2.10% |
| Cormorant Asset Management, LP | 450,000 | $43,839,000 | 1.69% |
| Duquesne Family Office | 543,901 | $52,987,000 | 1.54% |
| AWH Capital, L.P. | 9,500 | $925,000 | 1.30% |